Aclarion announces it enrolled ten KOLs to assist with Nociscan

Aclarion announced that they have successfully achieved their goal of enrolling ten leading spine surgery KOLs to assist the company in driving Nociscan to standard of care for identifying discogenic low back pain. “Since executing our IPO last year, Aclarion has consistently achieved catalysts of value creation that fall into a very concise framework of technology readiness, clinical evidence, and surgeon advocacy that are proven to bring disruptive technological advancements to standard of care in the healthcare sector,” said Brent Ness, Chief Executive Officer of Aclarion. “The steps we have taken in a short timeframe demonstrate that our actions follow our stated intentions. We are incredibly proud of the KOL panel that has rallied to help bring Nociscan to standard of care.”